This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Sunday, April 21, 2013
Hepatitis C - Watch Implications of resistance to direct-acting antivirals
Published on Apr 19, 2013
Hepatitis C Management - Professor Jean-Michel Pawlotsky
Professor Pawlotsky deliberates on the implications of resistance to
direct-acting antivirals.
No comments:
Post a Comment